Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease

Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease

Introduction: Although the prevalence of chronic obstructive pulmonary disease (COPD) is similar between men and women, current evidence used to support bronchodilator therapy has been generated in therapeutic trials that have predominately enrolled male patients. Here, we determined whether there i...

Full description

Bibliographic Details
Main Authors: Xuan Li, Ma'en Obeidat, Guohai Zhou, Janice M. Leung, Donald Tashkin, Robert Wise, John Connett, Philippe Joubert, Yohan Bossé, Maarten van den Berge, Corry-Anke Brandsma, David C. Nickle, Ke Hao, Peter D. Paré, Don D. Sin
Format: Article
Language:English
Published: Elsevier 2017-05-01
Series:EBioMedicine
Subjects:
Sex
FEV1
Ipratropium
COPD
Gene expression
Lung
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396417301639

Internet

http://www.sciencedirect.com/science/article/pii/S2352396417301639

Similar Items